Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Other financing activities: 2015-2024

Historic Other financing activities for Niagen Bioscience (NAGE) over the last 10 years, with Dec 2024 value amounting to $52,000.

  • Niagen Bioscience's Other financing activities was N/A to $6,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $64,000, marking a year-over-year change of. This contributed to the annual value of $52,000 for FY2024, which is 30.67% down from last year.
  • According to the latest figures from FY2024, Niagen Bioscience's Other financing activities is $52,000, which was down 30.67% from $75,000 recorded in FY2023.
  • Niagen Bioscience's Other financing activities' 5-year high stood at $110,000 during FY2021, with a 5-year trough of $49,000 in FY2020.
  • Its 3-year average for Other financing activities is $68,000, with a median of $75,000 in 2023.
  • Per our database at Business Quant, Niagen Bioscience's Other financing activities plummeted by 56.64% in 2020 and then spiked by 124.49% in 2021.
  • Yearly analysis of 5 years shows Niagen Bioscience's Other financing activities stood at $49,000 in 2020, then surged by 124.49% to $110,000 in 2021, then tumbled by 30.00% to $77,000 in 2022, then dropped by 2.60% to $75,000 in 2023, then crashed by 30.67% to $52,000 in 2024.